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Abstract 
G-proteins of the q family have been implicated as mediators of bombesin receptors action. We cloned Xenopus G, and G,,, and specifically 
disrupted the synthesis of either protein with selective antisense oligonucleotides. CC14 antisense inhibited responses mediated by neuromedin B receptor 
(NMB-R) by 74%, though not by gastrin-releasing peptide receptor (GRP-R). G,,, antisense had little effect on either GRP-R- or NMB-R-mediated 
responses. This suggests that NMB-R couples to G,_, and that GRP-R and NMB-R show distinct G-protein coupling preferences in the Xenopus 
oocyte. 
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1. Introduction 
Members of the Gq class of G protein a-subunits [1,2], 
have been implicated as transducers of the pertussis 
toxin-insensitive activation of phosphoinositide-specific 
phospholipase C (PI-PLC) [3-81. This signal transduc- 
tion pathway has been shown to be activated by bomb- 
esin receptor subtypes, gastrin releasing peptide receptor 
(GRP-R) [9-111 and neuromedin B receptor (NMB-R) 
1121. G,, and %, the most abundant members of the 
G, family, show high degree of homology (88% identity 
at the protein level) and appear to be co-expressed in 
most tissues [ 1,2,13,14]. Transfection experiments dem- 
onstrated PI-PLC activation by either G, or G,, , [ 151. 
Activation by IL-8 or muscarinic ml or m3 receptors of 
these G proteins failed to functionally distinguish be- 
tween G,, and Gall [l&19]. 
Mammalian bombesin-like peptides, GRP and NMB, 
regulate numerous physiologic processes including stim- 
ulation of hormone secretion, smooth muscle contrac- 
tion, thermoregulation (for review see [ZO]) and also the 
pathogenesis and progression of human small cell lung 
cancer [21]. GRP-R and NMB-R have been cloned and 
pharmacologically characterized after expression in Xen- 
opus oocytes [22-241. Both GRP-R [9-l l] and NMB-R 
[12] use a signal transduction pathway involving cou- 
pling to a PTX-insensitive G protein(s) that activates 
PI-PLC. Based on these similarities in pharmacology 
and signal transduction, we chose the Xenopus oocyte 
expression system combined with the antisense approach 
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The full sequences of oocyte G,, and G,,, will be submitted to the Gene 
Bank upon the acceptance of this manuscript for publication. 
to study the interactions of Xenopus G,, and Gall with 
mammalian GRP-R and NMB-R in an intact cell. 
Antisense oligonucleotides have been successfully used 
in rat pituitary GH3 cells to demonstrate that Gao, and 
Ga,,2 couple inhibitory responses mediated by muscarinic 
and somatostatin receptors, respectively [25] and in Xen- 
opus oocytes, to determine the subtypes of endogenous 
muscarinic receptors [26]. These studies provided prece- 
dents for using the antisense-induced protein depletion 
approach to define the specificity of receptor-G protein 
coupling. 
2. Materials and methods 
2.1. Cloning of Xenopus G, and G,,, 
Total RNA was isolated from Xenonus laevz& oocvtes and the polyad- 
enylated fraction was selected by ol&o(dT)-ccllul~se chromatography 
using established methods 1271. A hexamer-mimed cDNA library was 
cons&ted in AgtlO usini edtablished meihods [271, except for the 
size-fractionation of the cDNA prior to the ligation to the ngtl0 vector, 
which was carried out by Sepharose 4B chromatography rather than 
by polyacrylamide gel electrophoresis. Aooroximately 0.5 x lo6 plaques 
were Greened with a 32P-ladeled mous,-G, probe, obtained from a 
murine Swiss 3T3 ~olv(A)’ RNA bv reverse transcription followed by 
gene-specific PCR’an&&ation. &he probe included the entire 359 
amino acid open reading frame, with no flanking 5’ and 3’ untranslated 
sequences. Low stringency hybridization was performed overnight at 
37°C as previously described [24]. Filters were washed three times at 
room temperature for 15 min in 1 x SSC, 0.1% SDS and then at 37°C 
for 20 min in 0.1 x SSC, 0.1% SDS, dried and autoradiographed. Sub- 
cloned cDNA inserts were sequenced on both strands in a thermal 
cycler using both vector and insert-specific primers as recommended by 
the supplier (FMOL, Promega, Madison, WI). Nucleotide sequence 
analysis was performed using the Sequence Analysis Software Package 
of the University of Wisconsin Genetics Groups and a Vax computer 
WI. 
2.2. RNA analysis 
Groups of 50 Xenopus oocytes were microinjccted with 50 ng of either 
G, or G,,, antisense S-oligo (Oligos Etc. Ltd.). Control group was 
uninjected. Three hours later they were transferred into 8 ml of cold 
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guanidinisothiocyanate (GIT) buffer and RNA was isolated on CsCl 
gradient, as described elsewhere [27]. RNA samples (10 pg of total 
RNA) were resolved by electrophoresis on agarose/formaldehyde g l 
and blotted onto nitrocellulose membranes using standard methodol- 
ogy [24]. Filters were hybridized to “P-labeled Xenopus oocyte GW and 
G,,, cDNA probes as described previously [24]. Blots were washed at 
high stringency (3 x 10 min washes at room temperature in 1 x SSCl 
0.1% SDS, and one 15 min wash at 60°C in 0.1 x SSUO. 1% SDS), dried 
and autoradiographed. The mobility of 28s (5 kb) and 18s (2 kb) RNAs 
were determined by ethidium bromide staining. 
2.3. Functional assay 
Oocytes were excised from Xenopus laevis frogs (Xenopus I) and 
defolliculated with 2 mg/ml collagenase (Boehringer-Mannheim) in 
ND96 calcium-free buffer as described previously [29]. Oocytes were 
microinjected with l-10 ng of RNA in vitro transcribed from cDNAs 
encoding either NMB-R [24] or GRP-R [23] and kept in ND96 (96 mM 
NaCl, 2 mM KCl, 1 mM MgCl,, 1.8 mM CaCl,, 5 mM HEPES, pH 
7.5) at 20°C. 24 h later, the same oocytes were injected with 5-50 ng 
of Gq of G,,, antisense S-oligos (Oligos Etc. Inc.). Control oocytes 
were injected with water. Three hours following the injection of anti- 
sense oligonucleotides, individual oocytes were placed in a perfusion 
chamber, voltage-clamped at -100 mV and membrane currents were 
continuously recorded 1291. 10e6 M neuromedin B (an agonist of both 
bombesin receptor subtypes) in ND96 was added directly to the perfu- 
sion chamber. 
3. Results and discussion 
To design specific antisense oligonucleotides, we have 
cloned Xenopus oocytes cDNAs encoding Gw and G,_ 
We screened 5 x 10’ members of a Xenopus laevis oocyte 
cDNA library with a mouse G,, probe [l] at low strin- 
gency, and plaque-purified hybridizing cDNAs which 
were subsequently subcloned and sequenced. Alignment 
of the predicted amino acid sequences of the correspond- 
ing Xenopus proteins with mouse G,, and Gall revealed 
very high degree of homology (Gorq, 96% identity; Gal,, 
92% identity). The Xenopus G,, and Gal, amino acid 
sequences (Fig. 1) were 89% identical, the same level of 
identity observed in mouse G,, and Gali [l]. At the nu- 
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Fig. 1. Predicted amino acid sequences of Xenopus oocyte G,, (upper 
lane) and G,,, (lower lane). 
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Fig. 2. Specitic degradation of Xenopus oocyte G,,,, or G,,, mRNA 
induced by corresponding antisense S-oligos, as determined by RNA 
blot hybridization analysis. Total RNA from control oocytes (lane a) 
and oocytes microinjected with 4, (lane b) or G,,, (lane c) antisense 
S-oligos were resolved on agarose/formaldehyde g l and hybridized 
with oocyte 4, (A) or G,,, (B) probes. A 4.2 kb band of G,, (Aa) and 
a 3.4 kb band of G,,, (Bb) are present in control oocytes. G,, antisense 
caused the degradation of the G, band (Ab) and not the G,,, band 
(Bb). Conversely, G,, , antisense caused the degradation of the G,, , (Bc) 
band and not the Gq band (AC). In both cases, small amounts of a 
breakdown product of about 2.7-2.8 kb were detected. 
cleotide sequence level, the two cDNAs were identical in 
78% of the bases in the 1077 base open reading frame 
(data not shown). Northern analysis of Xenopus oocytes 
poly(A)’ RNA, using Xenopus G,, and Gorl, cDNA 
probes and high stringency hybridization conditions, de- 
tected hybridizing bands of about 4.2 kb for Gaq (Fig. 
2A, lane a) and 3.4 kb for G,, 1 (Fig. 2B, lane a), confirm- 
ing that both transcripts are present at detectable levels 
in Xenopus oocyte mRNA. 
In order to assess the role of G,, and G,, 1 in mediating 
GRP-R and NMB-R-induced responses in the oocytes, 
we designed discriminating antisense oligonucleotides 
complementary to a region of the G,,/G,,, cDNAs (se- 
quence encoding amino acids 120-126; Fig. l), whose 
nucleotide sequence was only 45% identical: 
Gag antisense: 5 ’ -ATTCTCAAAAGAGGCGACC - 3 ’ 
Gall antisense: 5 ’ -CTGTTCAAAGGTACATACT-3 ’ 
To test antisense-induced specific RNA degradation, 
oocytes were microinjected with 50 ng of either G,, or 
Gall antisense phosphorothioate oligonucleotides (S-oli- 
gos). Three hours after injection of the relevant anti- 
sense, Northern analysis did not detect bands of either 
Gaq (Fig. 2A, lane b) or G,,, (Fig. 2B, lane c). The 
ablation of transcripts was specific. G,, antisense did not 
interfere with G,,, RNA (Fig. 2A, lane c), while G,,, 
antisense did not interfere with G,, RNA (Fig. 2B, lane 
b). 
Oocytes expressing either the NMB-R or the GRP-R 
(10 ng of transcripts were microinjected the day before) 
were microinjected with either S-oligo antisense and 3-7 
h later were tested for characteristic agonist-induced 
membrane electrical responses, as previously described 
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Fig. 3. Effects of specific G, or G,,, antisense oligonucleotides on NMB-induced chloride currents, in oocytes expressing either NMB-R or GRP-R. 
(A,B) Traces of representative individual responses; A = NMB-R, and B = GRP-R-mediated responses, respectively. (a) Control; (b) antiQ-S-oligo- 
injected; c anti1 I-S-oligo-injected oocyte. (C) Summary of all experiments. In panel C, the open bar represents control responses mediated by either 
receptor (C). Black bars = responses in oocytes injected with NMB-R RNA, stippled bars = responses in oocytes injected with GRP-R RNA. 
[29]. Representative individual traces are shown in 
Fig. 3A,B and the summary of experiments is shown in 
Fig. 3C. G, antisense inhibited NMB-R-mediated re- 
sponses by 74% (26.3 + 5.0% of control response, 56 
oocytes from 9 donors; Fig. 3C). In most cases, the rapid 
component of the response (Dl) was completely abol- 
ished and the amplitude of the slow component (D2) was 
significantly inhibited, as shown in Fig. 3A. GRP-R me- 
diated responses were not affected by the G, antisense 
(91.4 f 8.1% of control responses, 127 oocytes from 14 
donors; Fig. 3C). The magnitude of the effects observed 
with either S-oligo was not affected by the amplitude of 
the response to NMB, nor by the amounts of RNA 
injected (l-10 ngloocyte, not shown). Hence, inhibition 
of G, synthesis affected the responses mediated by 
NMB-R but not by GRP-R. Glxll antisense S-oligo had 
virtually no effect on either GRP-R- or NMB-R-medi- 
ated responses (89.3 f 13.0% and 92.4 + 15.3% of con- 
trol responses, respectively; Fig. 3C). To test whether the 
NMB-R-induced response was mediated by both G,, 
and Gorll, we injected a mixture of both S-oligos. This 
treatment, however, did not further inhibit the response 
observed with Go4 antisense alone (not shown). Hence, 
efficient NMB-R coupling was sensitive to G,, depletion, 
but not Gal, depletion. 
Our results strongly suggest hat two bombesin recep- 
tor subtypes that utilize a similar signal transduction 
pathway, appear to couple to different G proteins. Fur- 
thermore, despite their remarkable structural similarity 
(89% amino acid identity), endogenous Gaq and Gal, do 
not appear to be functionally interchangeable for NMB- 
R coupling. 
The identity of the G-protein used to couple the GRP- 
R to PI-PLC is unclear. Despite extensive mRNA degra- 
dation, it is still possible that the residual protein level 
adequately supports GRP-R coupling. Another possi- 
bility is that GRP-R also couples through Gllq, but that 
the affinity of the receptor/G protein interaction is higher 
for GRP-R than NMB-R. Thus, a small amount of resid- 
ual G, remaining after antisense depletion was sufficient 
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to couple GRP-R but not NMB-R. Alternatively, the 
GRP-R may use neither G,, nor G,,, for coupling. Mo- 
riarty et al. [30] and Blitzer et al. [31], using microinjec- 
tion of the purified protein subunits into Xenopus 
oocytes, have proposed that G, mediates responses to 
serotonin and &,B-adrenergic receptors expressed in 
oocytes. Their conclusions were supported by an antis- 
ense experiment, in which oocytes were assayed 24 h 
after its injection. We have, therefore, injected an antis- 
ense S-oligo complementary to a unique oocyte G,, se- 
quence [32] (encoding the first 6 amino acids at the 
amino-terminus). This treatment had no effect on either 
NMB-R- or GRP-R-mediated responses up to 7 h after 
the injection of the oligonucleotide (not shown). Al- 
though in many target cells the effect of bombesin is 
PTX-insensitive [9], Moriarty et al. [33] reported that in 
Xenopus oocytes bombesin-evoked responses were inhib- 
ited by PTX. In our hands, functional assay for GRP-R 
and NMB-R in oocytes was PTX-insensitive (not 
shown), and exhibited a pharmacological profile similar 
to that observed in the tissues of origin [23,24,29]. We 
have no ready explanation for these discrepancies. 
In an earlier study, Lipinsky et al. [34] examined the 
effects of co-expressing either mouse Gaq or Gali with 
mouse thyrotropin releasing hormone (TRH) receptor in 
Xenopus oocytes, where co-expression of mouse G,i,, 
but not G _, potentiated responses. These observations 
are consistent with the conclusion of our study; although 
Gq and Gali are structurally very similar, they are not 
interchangeable for receptor coupling. Hence, this is the 
first demonstration of functional differences between a- 
tive Go4 and G,,, in an intact cell. 
Acknowledgements: This work was supported in part by a Bi-National 
Science Foundation Grant to Y.O. 
References 
[l] Strathmann, M. and Simon, M.I. (1990) Proc. Natl. Acad. Sci. 
USA 87, 9113-9117. 
[2] Wilkie, T.M., Scherle, P.A., Strathmann, M.P., Slepak, VS. and 
Simon, M.I. (1991) Proc. Natl. Acad. Sci. USA 88, 10049-10053. 
[3] Helper, J. and Gilman, A. (1992) Trends Biochem. Sci. 17, 383- 
387. 
[4] Smrcka, A.V., Hepler, J.R., Brown, K.O. and Sternweis, PC. 
(1991) Science 251, 804-807. 
[5] Berstein, G., Blank, J.L., Smrcka, A.V., Higashijima, T., 
Stemweis, PC., Exton, J.H. and Ross, E.M. (1992) J. Biol. Chem. 
267, 8081-8088. 
[6] Taylor, S.J., Chae, HZ., Rhee, S.G. and Exton, J.H. (1991) Na- 
ture 350, 516518. 
[7] Gutowski, S., Smrcka, A., Nowak, L., Wu, D., Simon, M. and 
Stemweis, P.C. (1991) J. Biol. Chem. 266, 20519-20524. 
[8] Shenker, A., Goldsmith, P., Unson, C.G. and Spiegel, A.M. (1991) 
J. Biol. Chem. 266, 9309-9313. 
[9] Fischer, J.B. and Schonbrunn, A. (1988) J. Biol. Chem. 263,2808- 
2816. 
[lo] Sharoni, Y., Viallet, J., Trepel, J. and Sausville, E. (1990) Cancer 
Res. 50, 5257-5262. 
[ll] Sinnett-Smith, J., Lehmann, W. and Rozengurt, E. (1990) Bio- 
them. J. 265,485493. 
[12] Benya, R., Wada, E., Battey, J., Fathi, Z., Wang, L.-H., Mantey, 
S., Coy, D. and Jensen, R. (1992) Mol. Pharmacol. 42, 1058-1068. 
[13] Milligan, G., Mullaney, I. and McCallum, F. (1993) B&him. 
Biophys. Acta 1179, 208-212. 
[14] Milligan, G. (1993) J. Neurochem. 61, 845-851. 
1151 Wu, D., Lee, C., Rhee, S. and Simon, M.I. (1992) J. Biol. Chem. 
267, 1811-1817. 
[16] Wu, D., LaRosa, G.J. and Simon, MI. (1993) Science 261, lOl- 
103. 
[17] Sawaki, K., Hiramatsu, Y., Baum, B.J. and Ambudkar, I.S. (1993) 
Arch. Biochem. Biophys. 305, 546-550. 
[18] Mullaney, I., Mitchell, EM., McCallum, J.F., Buckley, NJ. and 
Milligan, G. (1993) FEBS Lett. 324, 241-245. 
[19] Mitchell, EM., Buckley, N.J. and Milligan, G. (1993) B&hem. 
J. 293,495499. 
[20] Lebacq-Verheyden, A., Trepel, J., Sausville, E. and Battey, J. 
(1990) in: Peptide Growth Factors and Their Receptors II, Hand- 
book of Experimental Pharmacology Vol. 95/H, (M. Spom and A. 
Roberts, eds.), Springer Verlag, Heidelberg, pp. 71-124. 
[21] Cuttitta, F., Camey, D.N., Mulshine, J., Moody, T.W., Fedorko, 
J., Fischler, A. and Minna, J.D. (1985) Nature 316, 823-826. 
[22] Spindel, E.R., Giladi, E., Brehm, P., Goodman, R.H. and Seger- 
son, T.P. (1990) Mol. Endocrinol. 4, 1956-1963. 
[23] Battey, J.F., Way, J.M., Corjey, M.H., Shapira, H., Kusano, K., 
Harkins, R., Wu, J.M., Slattery, T., Mann, E. and Feldman, RI. 
(1991) Proc. Natl. Acad. Sci. USA 88, 395-399. 
[24] Wada, E., Way, J., Shapira, H., Kusano, K., Lebacq-Verheyden, 
A.M., Coy, D., Jensen, R. and Battey, J. (1991) Neuron 6, 421- 
430. 
[25] Kleuss, C., Heschler, J., Ewel, C., Rosenthal, W., Schultz, G. and 
Wittig, B. (1991) Nature 353, 43-48. 
[26] Matus-Leibovitch, N., Mengod, G. and Oron, Y. (1992) B&hem. 
J. 285, 753-758. 
[27] Davis, L., Dibner, M. and Battey, J.F. (1986) Basic Methods in 
Molecular Biology, pp. l-388, Elsevier, New York. 
[28] Devereux, J., Haeberlie, P. and Smithies, 0. (1984) Nucleic Acids 
Res. 12, 387-395. 
[29] Shapira, H., Wada, E., Battey, J.F., Jensen, R.J., Coy, D.H. and 
Kusano, K. (1991) Biochem. Biophys. Res. Commun. 176, 79- 
86. 
[30] Moriarty, T.M., Pardel, E., Carty, D.J., Omri, G., Landau, E.M. 
and Iyengar, R. (1990) Proc. Natl. Acad. Sci. USA 343, 79-82. 
[31] Blitzer, R.D., Gmri, G., De Viva, M., Catty, D.J., Premont, R.T., 
Codina, J., Bimbaumer, L., Cotecchia, S., Caron, M.G., Lefkow- 
itz, R.L., Landau, E.M. and Iyengar, R. (1993) J. Biol. Chem. 268, 
7532-7537. 
[32] Olate, J., Joquera, H., Purcell, P., Codina, J., Bimbaumer, L. and 
Allende, J.E. (1989) FEBS Lett. 244, 188-192. 
[33] Moriarty, T.M., Sealfon, S.C., Carty, D.J., Roberts, J.L., Iyengar, 
R. and Lamdau, E.M. (1989) J. Biol. Chem. 264, 13524 
13539. 
[34] Lipinsky, D., Gershengom, M. and Oron, Y. (1992) FEBS Lett. 
307. 237-240. 
